Maker of Costly Hepatitis C Drug Sovaldi Strikes Deal on Generics for Poor Countries

Gilead Sciences, the maker of one of the costliest drugs in the world announced on Monday, reports the New York Times, that it had struck deals with seven generic drug makers in India to sell lower-cost versions of the medicine — a $1,000-a-pill hepatitis C treatment — in poorer countries. Gilead, which is based in California, also said it would begin selling its own version of the drug in India and other developing countries at a fraction of the price it charges in the United States.